Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients.
Rukiye Derin AtabeyNesİm AladaĞAbdülcebbar ŞipalTayyar AkbulutZeki DoğanMahmut ÖzdemirPublished in: Revista da Associacao Medica Brasileira (1992) (2022)
This study failed to demonstrate a significant difference in preexisting cardiovascular diseases and cardiovascular medications between survivors and nonsurvivors who were admitted to ICU for severe COVID-19. Our findings indicate that the presence of chronic renal failure, a high peak ferritin concentration, and the need for invasive mechanical ventilation appear predictive for mortality. We propose that these risk factors should be taken into account in defining the risk status of severe COVID-19 patients admitted to the ICU.
Keyphrases
- coronavirus disease
- mechanical ventilation
- risk factors
- intensive care unit
- acute respiratory distress syndrome
- sars cov
- end stage renal disease
- early onset
- cardiovascular disease
- cardiovascular events
- chronic kidney disease
- drug induced
- respiratory syndrome coronavirus
- ejection fraction
- newly diagnosed
- type diabetes
- metabolic syndrome
- human health